Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 2/20 | 0.48 |
| ▸ | RORC | P51449 | 9/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.45 |
| ▸ | ACSS2 | Q9NR19 | 1/20 | 0.45 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.43 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.43 |
| ▸ | SRC | P12931 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21599721 | 0.92 | PTGER4 (0.59) | PTGER4RORCACSS2 | |
| SCHEMBL21076080 | 0.85 | RORC (0.52) | PTGER4RORCCYP2A6ACSS2 | |
| SCHEMBL21547074 | 0.81 | PTGER4 (0.43) | PTGER4RORCROCK2 | |
| SCHEMBL5892136 | 0.81 | PTGER4 (0.63) | PTGER4RORC | |
| SCHEMBL29643208 | 0.81 | PTGER4 (0.63) | PTGER4RORC | |
| SCHEMBL1052309 | 0.81 | KDM4E (0.39) | PTGER4RORCSRC | |
| SCHEMBL4555901 | 0.81 | KDM4E (0.49) | ACSS2CYP11B2CYP11B1 | |
| SCHEMBL18030923 | 0.78 | L3MBTL1 (0.41) | CYP2A6SRC | |
| SCHEMBL7973614 | 0.76 | KDM4E (0.62) | PTGER4RORC | |
| SCHEMBL7491601 | 0.75 | CYP11B2 (0.46) | PTGER4CYP2A6ACSS2CYP11B2CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190173019-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | Kyulux North America, Inc. | 2019-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190173019-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | CRY2, ALDH1A2, CYBA | PTGER4 1478/4885RORC 639/4885CYP2A6 485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.